Management of Large B-Cell Lymphomas: A Critical Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma and CAR T-Cell Therapy

Access Activity

Overview / Abstract:

Hematologist-oncologists, pathologists, histologists, advanced practitioners, oncology nurses, pharmacists, and other healthcare professionals involved in the care of patients diagnosed with LBCL.
In this activity, Jeremy Abramson, MD, highlights the significant disease burden of B-cell lymphomas, as well as the latest advances in therapeutics, and practical strategies for integrating novel therapies into practice through patient selection and supportive care management.
Upon completion of this activity, participants should be better able to:
• Review the disease state, clinical and molecular heterogeneity, and unmet needs, including the clinical and healthcare resource burden of LBCL
• Describe the mechanism of action and appraise available clinical safety and efficacy data and indications for new agents for the treatment of LBCL, especially R/R LBCL, to select optimal treatments
• Integrate approaches for identifying patients eligible for chimeric antigen receptor T-cell (CAR T-cell) therapy and applying suitable bridging therapies
• Incorporate approaches for identifying, monitoring, and managing therapy-associated toxicities and AEs, including CAR T-cell–associated toxicities, for patients with LBCL


Jun 10, 2023


Nursing CNE, Pharmacy CPE, Physician CME



Credits / Hours




Presenters / Authors / Faculty

Jeremy Abramson, MD
Advisory Board: AbbVie, Century Therapeutics, Lilly, Mustang Bio, Regeneron

Consultant: AstraZeneca, BeiGene, Bluebird Bio, Bristol Myers Squibb, Epizyme, Genentech, Genmab, Incyte, Kite Pharma, Kymera, MorphoSys, Ono Pharma

Additional content planners
The following have no significant relationship to disclose:
Christopher Elder, PharmD, BCOP (medical writer)
Kam Newman, MD (peer reviewer)
Heather M. Jimenez, FNP-C (nurse reviewer)

Sponsors / Supporters / Grant Providers

Bristol Myers Squibb

Keywords / Search Terms

Relias LLC Relias LLC Relias, Free CME, Large B-Cell Lymphoma Free CE CME Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map